CD34 and acute respiratory distress syndrome: Given the easy availability, rapid purification procedure without defects from in vitro culture, and low immunogenicity of these cells [52] as well as the nature of rapid progression of ALI/ARDS, fCB-CD34+ cells may be an important source of stem cells for the prevention and treatment of ALI/ARDS.